Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Social Determinants of Health Research Center, Babol University of Medical Sciences, Babol, Iran.
BMC Infect Dis. 2024 Jan 11;24(1):77. doi: 10.1186/s12879-024-08991-0.
This study aimed to assess the construct validity and reliability of the Iranian version of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) among the elderly population.
A cohort of 230 elderly individuals who tested positive for Covid-19 via PCR were administered a health and demographic information questionnaire along with the C19-YRS. Both exploratory and confirmatory factor analyses were conducted, and Cronbach's alpha was calculated.
Findings from the exploratory and confirmatory factor analyses of the C19-YRS revealed alterations compared to the original version, resulting in an adapted version with three factors achieved by redistributing the questions. These factors accounted for 57.46% of the total variance. Despite a relatively lower factor loading in the 6th question, it was retained due to its significance among the elderly. The Cronbach's alpha for the C19-YRS subscales ranged from 0.730 to 0.890, indicating acceptable reliability.
The validation results indicated a well-adjusted factor structure and internal consistency, affirming the utility of this tool among the elderly population. Consequently, the C19-YRS in Iran can serve as a valuable resource in healthcare settings, aiding in the assessment of chronic complications arising from Covid-19 in the elderly. It can be utilized as an initial screening or triage test and to evaluate the effectiveness of interventions.
本研究旨在评估伊朗版 COVID-19 约克郡康复量表(C19-YRS)在老年人群中的结构效度和信度。
对 230 名经 PCR 检测 COVID-19 呈阳性的老年人进行健康和人口统计学信息问卷以及 C19-YRS 调查。同时进行了探索性和验证性因子分析,并计算了克朗巴赫的α值。
C19-YRS 的探索性和验证性因子分析结果与原始版本相比发生了变化,通过重新分配问题得出了一个具有三个因素的适应版本。这些因素占总方差的 57.46%。尽管第 6 个问题的因子负荷相对较低,但由于其在老年人中的重要性,仍被保留。C19-YRS 分量表的克朗巴赫的α值在 0.730 到 0.890 之间,表明具有可接受的信度。
验证结果表明,该工具具有良好的调整后的因子结构和内部一致性,证实了它在老年人群中的实用性。因此,伊朗的 C19-YRS 可以在医疗保健环境中作为有价值的资源,有助于评估老年人 COVID-19 引起的慢性并发症。它可以作为初始筛查或分诊测试,并用于评估干预措施的效果。